Patents by Inventor Brenda E. Reynolds

Brenda E. Reynolds has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5888541
    Abstract: Increase gut calcium absorption in humans or animals by the administration of GLA, DGLA or LA as such or in salt or other pharmacologically acceptable form, optionally in association with EPA, DHA or other EFA in similar forms, specifically useful in the treatment of osteoporosis.
    Type: Grant
    Filed: January 15, 1997
    Date of Patent: March 30, 1999
    Assignee: Scotia Holdings PLC
    Inventors: David F. Horrobin, Brenda E. Reynolds
  • Patent number: 5618558
    Abstract: Increasing gut calcium absorption in humans or animals by the administration of GLA, DGLA or LA as such or in salt or other pharmacologically acceptabe form, optionally in association with EPA, DHA or other EFA in similar forms, specifically useful in treatment of osteoporosis.
    Type: Grant
    Filed: August 16, 1993
    Date of Patent: April 8, 1997
    Assignee: Scotia Holdings PLC
    Inventors: David F. Horrobin, Brenda E. Reynolds
  • Patent number: 5516801
    Abstract: Prevention and/or treatment of abnormal calcification in any tissue by the administration of (i) GLA and/or its EFA metabolites, and in particular the rapidly produced DGLA and/or (ii) EPA and/or its precursors, stearidonic acid and 20:4 n-3, and metabolites, docosahexaenoic acid (DHA) or docosapenmenoic acid (22:5 n-3), as such or in salt or other pharmacologically acceptable form. This is especially suitable for prevention or treatment of nephrocalcinosis and/or renal stones.
    Type: Grant
    Filed: December 28, 1994
    Date of Patent: May 14, 1996
    Assignee: Scotia Holdings plc
    Inventors: David F. Horrobin, Brenda E. Reynolds